全文获取类型
收费全文 | 6877篇 |
免费 | 343篇 |
国内免费 | 208篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 214篇 |
妇产科学 | 159篇 |
基础医学 | 1121篇 |
口腔科学 | 76篇 |
临床医学 | 346篇 |
内科学 | 1331篇 |
皮肤病学 | 47篇 |
神经病学 | 1061篇 |
特种医学 | 247篇 |
外科学 | 577篇 |
综合类 | 621篇 |
预防医学 | 294篇 |
眼科学 | 56篇 |
药学 | 708篇 |
1篇 | |
中国医学 | 415篇 |
肿瘤学 | 128篇 |
出版年
2023年 | 42篇 |
2022年 | 97篇 |
2021年 | 136篇 |
2020年 | 104篇 |
2019年 | 194篇 |
2018年 | 213篇 |
2017年 | 160篇 |
2016年 | 132篇 |
2015年 | 150篇 |
2014年 | 224篇 |
2013年 | 296篇 |
2012年 | 267篇 |
2011年 | 316篇 |
2010年 | 245篇 |
2009年 | 255篇 |
2008年 | 275篇 |
2007年 | 263篇 |
2006年 | 282篇 |
2005年 | 233篇 |
2004年 | 227篇 |
2003年 | 221篇 |
2002年 | 186篇 |
2001年 | 178篇 |
2000年 | 145篇 |
1999年 | 119篇 |
1998年 | 120篇 |
1997年 | 132篇 |
1996年 | 92篇 |
1995年 | 88篇 |
1994年 | 87篇 |
1993年 | 75篇 |
1992年 | 43篇 |
1991年 | 55篇 |
1990年 | 60篇 |
1989年 | 51篇 |
1988年 | 42篇 |
1986年 | 29篇 |
1985年 | 89篇 |
1984年 | 67篇 |
1983年 | 54篇 |
1982年 | 94篇 |
1981年 | 107篇 |
1980年 | 128篇 |
1979年 | 114篇 |
1978年 | 123篇 |
1977年 | 102篇 |
1976年 | 170篇 |
1975年 | 169篇 |
1974年 | 172篇 |
1973年 | 167篇 |
排序方式: 共有7428条查询结果,搜索用时 31 毫秒
1.
《Research in social & administrative pharmacy》2022,18(9):3694-3698
In this paper, we argue that understanding and addressing the problem of poor-quality medical products requires a more interdisciplinary approach than has been evident to date. While prospective studies based on rigorous standardized methodologies are the gold standard for measuring the prevalence of poor-quality medical products and understanding their distribution nationally and internationally, they should be complemented by social science research to unpack the complex set of social, economic, and governance factors that underlie these patterns. In the following sections, we discuss specific examples of prospective quality surveys and of social science studies, highlighting the value of cross-sector partnerships in driving high-quality, policy-relevant research in this area. 相似文献
2.
《Diagnostic and interventional imaging》2020,101(9):555-564
PurposeThe purpose of this study was to determine whether computed tomography (CT)-based machine learning of radiomics features could help distinguish autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDAC).Materials and MethodsEighty-nine patients with AIP (65 men, 24 women; mean age, 59.7 ± 13.9 [SD] years; range: 21–83 years) and 93 patients with PDAC (68 men, 25 women; mean age, 60.1 ± 12.3 [SD] years; range: 36–86 years) were retrospectively included. All patients had dedicated dual-phase pancreatic protocol CT between 2004 and 2018. Thin-slice images (0.75/0.5 mm thickness/increment) were compared with thick-slices images (3 or 5 mm thickness/increment). Pancreatic regions involved by PDAC or AIP (areas of enlargement, altered enhancement, effacement of pancreatic duct) as well as uninvolved parenchyma were segmented as three-dimensional volumes. Four hundred and thirty-one radiomics features were extracted and a random forest was used to distinguish AIP from PDAC. CT data of 60 AIP and 60 PDAC patients were used for training and those of 29 AIP and 33 PDAC independent patients were used for testing.ResultsThe pancreas was diffusely involved in 37 (37/89; 41.6%) patients with AIP and not diffusely in 52 (52/89; 58.4%) patients. Using machine learning, 95.2% (59/62; 95% confidence interval [CI]: 89.8–100%), 83.9% (52:67; 95% CI: 74.7–93.0%) and 77.4% (48/62; 95% CI: 67.0–87.8%) of the 62 test patients were correctly classified as either having PDAC or AIP with thin-slice venous phase, thin-slice arterial phase, and thick-slice venous phase CT, respectively. Three of the 29 patients with AIP (3/29; 10.3%) were incorrectly classified as having PDAC but all 33 patients with PDAC (33/33; 100%) were correctly classified with thin-slice venous phase with 89.7% sensitivity (26/29; 95% CI: 78.6–100%) and 100% specificity (33/33; 95% CI: 93–100%) for the diagnosis of AIP, 95.2% accuracy (59/62; 95% CI: 89.8–100%) and area under the curve of 0.975 (95% CI: 0.936–1.0).ConclusionsRadiomic features help differentiate AIP from PDAC with an overall accuracy of 95.2%. 相似文献
3.
Cadmium is a toxic metal that can damage the brain and other organs. This study aimed to explore the protective effects of Potentilla anserine L. polysaccharide (PAP) against CdCl2-induced neurotoxicity in N2a and SH-SY5Y cells and in the cerebral cortex of BALB/c mice. In addition, we aimed to identify the potential mechanisms underlying these protective effects. Relative to CdCl2 treatment alone, pretreatment with PAP prevented the reduction in cell viability evoked by CdCl2, decreased rates of apoptosis, promoted calcium homeostasis, decreased ROS accumulation, increased mitochondrial membrane potential, inhibited cytochrome C and AIF release, and prevented the cleavage of caspase-3 and PARP. In addition, PAP significantly decreased the CdCl2-induced phosphorylation of CaMKII, Akt, and mTOR. In conclusion, PAP represents a potential therapeutic agent for the treatment of Cd-induced neurotoxicity, functioning in part via attenuating the activation of the mitochondrial apoptosis pathway and the Ca2+-CaMKII-dependent Akt/mTOR pathway. 相似文献
4.
Marta López-Fauqued Laura Campora Frédérique Delannois Mohamed El Idrissi Lidia Oostvogels Ferdinandus J. De Looze Javier Diez-Domingo Thomas C. Heineman Himal Lal Janet E. McElhaney Shelly A. McNeil Wilfred Yeo Fernanda Tavares-Da-Silva 《Vaccine》2019,37(18):2482-2493
Background
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.Methods
Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.Results
Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.Conclusions
No safety concerns arose, supporting the favorable benefit-risk profile of RZV. 相似文献5.
6.
盐酸氟西汀对抑郁症模型小鼠神经肽Y表达的研究 总被引:3,自引:0,他引:3
目的 探讨盐酸氟西汀对慢性应激抑郁症模型小鼠下丘脑神经肽Y(NPY)的表达影响。方法 采用旷场试验(Open-Field)法,比较抑郁症模型小鼠与正常对照组行为学改变方面的差异。将慢性应激抑郁症小鼠模型随机分成盐酸氟西汀和阿米替林治疗组、模型对照组,同时设立空白对照组,利用半定量逆转录.聚合酶联反应(RT-PCR)法、细胞酶联免疫法和蛋白免疫印迹(Western-blot)技术,比较试验组小鼠下丘脑NPY的表达变化。结果 (1)与正常组比较,模型组在总路程缩短、活动斑数减少和体重增加幅度下降等方面具有显著性差异。(2)与正常组比较,抑郁症模型组下丘脑NPY的mRNA表迭下降。(3)经过3周的治疗,盐酸氟西汀组和阿米替林组小鼠下丘脑NPY的mRNA及蛋白表达没有明显差别,但是两组的表达结果显著高于模型对照组,与空白对照组的结果接近。结论 脑内NPY的mRNA及蛋白的表达增加可能是盐酸氟西汀治疗抑郁症小鼠的机制之一。 相似文献
7.
补肾排毒合剂治疗慢性肾衰竭营养不良60例临床观察 总被引:1,自引:0,他引:1
目的:观察补肾排毒合剂治疗慢性肾衰竭营养不良的疗效.方法:90例慢性肾衰竭营养不良患者随机分为治疗组60例和对照组30例,并设健康对照组30例.治疗组和对照组在综合治疗的基础上,治疗组加用补肾排毒合剂,对照组加用爱西特和百令胶囊.比较两组肾功能、营养状态和血浆瘦素、神经肽Y的变化.结果:治疗组治疗后BUN、Scr明显降低,与治疗前及对照组相比均有统计学差异(P<0.05).治疗组营养状态好转,与治疗前及对照组相比均有统计学差异(P<0.05).两组慢性肾衰竭营养不良患者治疗前Leptin、NPY水平均高于健康组(P<0.05),治疗后治疗组Leptin、NPY较治疗前下降,有统计学意义(P<0.05),但与对照组相比无统计学差异(P>0.05).结论:补肾排毒合剂治疗慢性肾衰竭营养不良疗效明显,可降低BUN、Scr,改善营养不良状态. 相似文献
8.
J. Carleson P. Kogner I. Bileviciute E. Theodorsson A. Appelgren B. Appelgren S. Kopp N. Yousef T. Lundeberg 《Archives of oral biology》1997,42(12):869-876
Temporomandibular joint (TMJ) arthritis was induced in female Lewis rats by unilateral injection of a suspension of heat-killed Mycobacterium butyricum in paraffin oil into the TMJ. Control rats received paraffin oil by the same route. Arthritic and control rats were pretreated either with capsaicin or denervation of the mandibular branch of the trigeminal nerve. Tissues were collected for neuropeptide extraction and analysed by radioimmunoassay and reverse-phase high-performance liquid chromatography. In all groups, the levels of substance P- (SP), calcitonin gene-related peptide- (CGRP) and neuropeptide Y- (NPY) like immunoreactivity (LI) were higher in the trigeminal ganglia than in the TMJs. In control rats, capsaicin significantly lowered the levels of SP-LI in the trigeminal ganglia and TMJ, but not CGRP-LI and NPY-LI. In the arthritic rats, capsaicin pretreatment significantly lowered the SP-LI and CGRP-LI in the trigeminal ganglia and TMJ, but not the NPY-LI. In the trigeminal ganglia the unilateral denervation significantly lowered SP-LI in control rats, and in arthritic rats SP-LI and CGRP-LI. On the denervated side of the arthritic TMJ, NPY-LI, SP-LI and CGRP- LI were significantly lowered as compared to the arthritic control rats and to the contralateral side. In this rat model, pretreatment with capsaicin and surgical denervation decreased the neuropeptide content in the trigeminal ganglia and the TMJ. The results clearly demonstrate a close interaction between increased neuropeptide release from sensory and sympathetic neurones after induction of arthritis in the rat. 相似文献
9.
10.
神经肽Y标记神经元在大鼠脑桥的分布 总被引:1,自引:0,他引:1
目的:观察了神经肽Y(NPY)样神经元在大鼠脑桥的分布,为探讨脑桥NPY样神经元的功能提供实验形态学依据。方法:免疫组织化学方法(PAP法)。结果:在脑桥可见到前庭神经上核、耳蜗神经腹侧核及脑桥尾侧网状核NPY样免疫反应胞体。前庭神经上核的NPY样胞体较多且密集,细胞大小均匀,呈梭形或椭圆形,有明显突起;耳蜗神经腹侧核内的NPY样胞体呈大小均匀分布,圆形且较小,突起不明显;脑桥尾侧网状核内的NPY样胞体分布较稀疏,且大小不一,呈菱形或梭形,有明显较长的突起。结论:NPY样神经元不仅广泛存在于端脑和下丘脑,在脑桥也同样有着广泛的分布。 相似文献